Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109 – PR Newswire
Posted by admin
on Tuesday, March 24, 2026 at 12:00 pm — No Comments | Leave a Comment
Leave a Comment